Bio View

Bio View Acquisitions (Net)

The Acquisitions (Net) of Bio View (BIOV.TA) as of Oct 19, 2026 is -1.51 M ILS. In the previous year, Acquisitions (Net) was -1.40 M ILS — a change of 7.79% (lower).

Acquisitions (Net)

-1.51 MILS

YoY

7.79%

Last updated:

Acquisitions (Net) of Bio View is 2024 -1.51 M ILS. Acquisitions (Net) of Bio View was 2023 -1.40 M ILS. It decreases by 7.79% lower compared to the previous year.

The Bio View Acquisitions (Net) history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Acquisitions (Net)
Date
Acquisitions (Net)
Jan 1, 2017
0.00 ILS
Jan 1, 2018
-14,000.00 ILS
Jan 1, 2019
-18,000.00 ILS
Jan 1, 2020
-9,000.00 ILS
Jan 1, 2021
-81,000.00 ILS
Jan 1, 2022
-110,000.00 ILS
Jan 1, 2023
-1.40 M ILS
Jan 1, 2024
-1.51 M ILS
The Bio View Acquisitions (Net) history
YEARAcquisitions (Net)YoY
-1.51 MILS+7.79%
-1.40 MILS+1,171.82%
-110,000.00ILS+35.80%
-81,000.00ILS+800.00%
-9,000.00ILS-50.00%
-18,000.00ILS+28.57%
-14,000.00ILS—
0.00ILS—
0.00ILS-100.00%
-6,000.00ILS+200.00%
-2,000.00ILS—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bio View Stock analysis

What does Bio View do? Bio View Ltd, based in Rehovot, Israel, operates in the Health Care sector, specializing in the research, development, marketing, and sales of advanced imaging systems. The company manufactures and services the Duet workstation, an automated cell diagnostic system used in cytology, hematology, and pathology laboratories for detecting and analyzing abnormal cells. It also offers the ALLEGRO and ACCORD workstations for specialized applications in cancer diagnosis, minimal-residual disease monitoring, and FISH-based analyses in cytogenetics and oncology. Bio View is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio View stock

Acquisitions (Net) of Bio View is -1.51 M ILS in 2024.

Acquisitions (Net) of Bio View changed from -1.40 M ILS to -1.51 M ILS, representing a 7.79% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Acquisitions (Net) Bio View since 2006 – with annual values, charts, and detailed analysis.

Net acquisitions represent the cash spent on acquiring other businesses, net of divestitures. Large acquisitions can transform a company's growth trajectory.

Acquisitions (Net)'s ILS is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Acquisitions (Net)'s Bio View historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Bio View

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Bio View